Radioactive 'seeds' save time, may improve outcomes for breast cancer patients

September 25, 2012

(Medical Xpress)—Magee-Womens Hospital of UPMC is the first and only hospital in western Pennsylvania to offer radioactive seed localization, an innovation allowing breast tumors that cannot be felt to be precisely located before surgery.

The procedure offers greater convenience and may potentially improve outcomes for some . The seed is a tiny metal capsule containing a small amount of radioactive material which is inserted into the breast using a small-gauge needle and mammographic or sonographic guidance to mark the tumor site. During surgery, the seed can be detected using a special probe designed to detect the radioactive signature of the seed, allowing the surgeon to choose an incision site strictly based on cosmetic concerns and the location of the tumor. At Magee, the seed can be placed within the week prior to surgery, although most often it is placed shortly before surgery.

Without the availability of radioactive seed localization, certain surgeries require patients to undergo a procedure called breast needle localization in which a preoperative wire is inserted into the breast to identify the location of the breast lesion. The wire can remain in the breast for several hours and is used to guide the surgeon during the operation later the same day.

"From a scheduling perspective, breast needle localization requires the patient to arrive at the hospital well in advance of her surgery, which often causes significant inconvenience for her, especially if an early-morning operation is planned," said Jules Sumkin, D.O., chief of at Magee. "In addition, the entrance site of the wire through the skin often is not where the surgeon prefers to make an when taking tumor location and cosmetic concerns into consideration. Radioactive seed localization solves both issues."

To date, Magee have performed over 500 radioactive seed localization procedures, making it the most experienced program in the country.

"This technology is convenient for the patient, surgeon and the radiologist, and, more importantly, shows promise in improving surgical outcomes," said Marguerite Bonaventura, M.D., a surgical oncologist with Magee who worked with Dr. Sumkin to bring the technology, which was pioneered at the Mayo Clinic, to Pittsburgh. "Studies suggest radioactive seed localization results in more precise removal of small breast cancers and reduces the need for a second surgery due to incomplete removal of the abnormal tissue."

Explore further: Most breast cancer patients do not have breast reconstruction surgery

Related Stories

Most breast cancer patients do not have breast reconstruction surgery

October 20, 2011
Only seven per cent of female breast cancer patients opt for breast reconstruction surgery.

Radiation at time of lumpectomy may offer faster, more precise treatment for breast cancer patients

April 12, 2011
Northwestern Medicine physicians are currently utilizing a new treatment option for breast cancer that allows women to receive a full dose of radiation therapy during breast conserving surgery. Traditionally, women who opt ...

Recommended for you

Drug suppresses spread of breast cancer caused by stem-like cells

December 12, 2017
Rare stem-like tumor cells play a critical role in the spread of breast cancer, but a vulnerability in the pathway that powers them offers a strategy to target these cells using existing drugs before metastatic disease occurs, ...

MRI scans predict patients' ability to fight the spread of cancer

December 12, 2017
A simple, non-invasive procedure that can indicate how long patients with cancer that has spread to the brain might survive and whether they are likely to respond to immunotherapy has been developed by researchers in Liverpool.

A new weapon against bone metastasis? Team develops antibody to fight cancer

December 11, 2017
In the ongoing battle between cancer and modern medicine, some therapeutic agents, while effective, can bring undesirable or even dangerous side effects. "Chemo saves lives and improves survival, but it could work much better ...

Insights on how SHARPIN promotes cancer progression

December 11, 2017
Researchers at Sanford Burnham Prebys Medical Discovery (SBP) and the Technion in Israel have found a new role for the SHARPIN protein. In addition to being one of three proteins in the linear ubiquitin chain assembly complex ...

Glioblastoma survival mechanism reveals new therapeutic target

December 11, 2017
A Northwestern Medicine study, published in the journal Cancer Cell, has provided new insights into a mechanism of tumor survival in glioblastoma and demonstrated that inhibiting the process could enhance the effects of radiation ...

Liver cancer: Lipid synthesis promotes tumor formation

December 11, 2017
Lipids comprise an optimal energy source and an important cell component. Researchers from the Biozentrum of the University of Basel and from the University of Geneva have now discovered that the protein mTOR stimulates the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.